341 related articles for article (PubMed ID: 20079455)
1. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
2. PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.
Castillero E; Alamdari N; Aversa Z; Gurav A; Hasselgren PO
PLoS One; 2013; 8(3):e59726. PubMed ID: 23555761
[TBL] [Abstract][Full Text] [Related]
3. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
4. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
5. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
[TBL] [Abstract][Full Text] [Related]
6. Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle.
Menconi MJ; Arany ZP; Alamdari N; Aversa Z; Gonnella P; O'Neal P; Smith IJ; Tizio S; Hasselgren PO
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E533-43. PubMed ID: 20647557
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
8. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle.
Crossland H; Constantin-Teodosiu D; Gardiner SM; Constantin D; Greenhaff PL
J Physiol; 2008 Nov; 586(22):5589-600. PubMed ID: 18818241
[TBL] [Abstract][Full Text] [Related]
9. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
10. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.
Alamdari N; Smith IJ; Aversa Z; Hasselgren PO
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R509-20. PubMed ID: 20538901
[TBL] [Abstract][Full Text] [Related]
11. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression.
Fareed MU; Evenson AR; Wei W; Menconi M; Poylin V; Petkova V; Pignol B; Hasselgren PO
Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1589-97. PubMed ID: 16455766
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
13. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.
Frost RA; Nystrom GJ; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E501-12. PubMed ID: 17003238
[TBL] [Abstract][Full Text] [Related]
14. C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1.
Gonnella P; Alamdari N; Tizio S; Aversa Z; Petkova V; Hasselgren PO
J Cell Biochem; 2011 Jul; 112(7):1737-48. PubMed ID: 21381078
[TBL] [Abstract][Full Text] [Related]
15. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
[TBL] [Abstract][Full Text] [Related]
16. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Ligustrazine on expressions of FoXO3a, MAFbx, and MuRF1 in denervated skeletal muscle atrophy rats].
Wang H; Liang B; Peng C; Wang P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 May; 26(5):597-600. PubMed ID: 22702057
[TBL] [Abstract][Full Text] [Related]
18. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
19. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
[TBL] [Abstract][Full Text] [Related]
20. Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor.
Zhao W; Qin W; Pan J; Wu Y; Bauman WA; Cardozo C
Biochem Biophys Res Commun; 2009 Jan; 378(3):668-72. PubMed ID: 19059383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
